|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| A61K 31/519 | |||
| A61K 31/53 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3268490 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16710115.3 |
| Europos patento paraiškos padavimo data | 2016-03-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-01-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/054727 |
| Data | 2016-03-07 |
| (87) | Numeris | WO 2016/142312 |
| Data | 2016-09-15 |
| (30) | Numeris | Data | Šalis |
| 201562130418 P | 2015-03-09 | US |
| (72) |
LIU, Ningshu, DE
PENA, Carol, US
JEFFERS, Michael, US
GENVRESSE, Isabelle, DE
|
| (73) |
Bayer Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
Bayer Healthcare Pharmaceuticals Inc., 100 Bayer Boulevard, Whippany, New Jersey 07981, US |
| (54) | SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE-CONTAINING COMBINATIONS |
| SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE-CONTAINING COMBINATIONS |